OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Molecular Targets in Cholangiocarcinoma
Colm J. O’Rourke, Patricia Muñoz-Garrido, Jesper B. Andersen
Hepatology (2020) Vol. 73, Iss. S1, pp. 62-74
Closed Access | Times Cited: 33
Colm J. O’Rourke, Patricia Muñoz-Garrido, Jesper B. Andersen
Hepatology (2020) Vol. 73, Iss. S1, pp. 62-74
Closed Access | Times Cited: 33
Showing 26-50 of 33 citing articles:
Differential in vitro effects of targeted therapeutics in primary human liver cancer: importance for combined liver cancer
Ihtzaz Ahmed Malik, Mansi Rajput, Rieke Werner, et al.
BMC Cancer (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 7
Ihtzaz Ahmed Malik, Mansi Rajput, Rieke Werner, et al.
BMC Cancer (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 7
Molecular Landscape and Therapeutic Strategies in Cholangiocarcinoma: An Integrated Translational Approach towards Precision Medicine
Marco Casadio, Francesca Biancaniello, Diletta Overi, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 5613-5613
Open Access | Times Cited: 9
Marco Casadio, Francesca Biancaniello, Diletta Overi, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 5613-5613
Open Access | Times Cited: 9
Chidamide Suppresses the Growth of Cholangiocarcinoma by Inhibiting HDAC3 and Promoting FOXO1 Acetylation
Yongpan Li, Jujia Zheng, Qiang Huo, et al.
Stem Cells International (2022) Vol. 2022, pp. 1-15
Open Access | Times Cited: 5
Yongpan Li, Jujia Zheng, Qiang Huo, et al.
Stem Cells International (2022) Vol. 2022, pp. 1-15
Open Access | Times Cited: 5
High expression of CCDC6 in relation to unfavorable outcome and immune cells infiltration in hepatobiliary carcinoma
Tianyu Wu, Xiaoqing Jiang, Bin Xu, et al.
Journal of Cancer (2022) Vol. 13, Iss. 12, pp. 3378-3395
Open Access | Times Cited: 5
Tianyu Wu, Xiaoqing Jiang, Bin Xu, et al.
Journal of Cancer (2022) Vol. 13, Iss. 12, pp. 3378-3395
Open Access | Times Cited: 5
Chitosan Hydrogel Incorporated with Bone Marrow Mesenchymal Stem Cell-derived Exosomal TIMP2 to Inhibit Angiogenesis in Cholangiocarcinoma
Fei Song, Dan Xu, Jiayin Che, et al.
Tissue and Cell (2024) Vol. 93, pp. 102694-102694
Closed Access
Fei Song, Dan Xu, Jiayin Che, et al.
Tissue and Cell (2024) Vol. 93, pp. 102694-102694
Closed Access
The Cytomorphologic and Molecular Assessment of Bile Duct Brushing Specimens
Caroline F. Hilburn, Martha B. Pitman
Surgical pathology clinics (2022) Vol. 15, Iss. 3, pp. 469-478
Closed Access | Times Cited: 1
Caroline F. Hilburn, Martha B. Pitman
Surgical pathology clinics (2022) Vol. 15, Iss. 3, pp. 469-478
Closed Access | Times Cited: 1
Progress Toward Improving Outcomes in Patients with Cholangiocarcinoma
Hiroko Kawasaki, Yuko Akazawa, Nataliya Razumilava
Current Treatment Options in Gastroenterology (2021) Vol. 19, Iss. 1, pp. 153-168
Open Access | Times Cited: 1
Hiroko Kawasaki, Yuko Akazawa, Nataliya Razumilava
Current Treatment Options in Gastroenterology (2021) Vol. 19, Iss. 1, pp. 153-168
Open Access | Times Cited: 1
Molecular-driven treatment for biliary tract cancer: the promising turning point
Mara Persano, Marco Puzzoni, Pina Ziranu, et al.
Expert Review of Anticancer Therapy (2021) Vol. 21, Iss. 11, pp. 1253-1264
Closed Access
Mara Persano, Marco Puzzoni, Pina Ziranu, et al.
Expert Review of Anticancer Therapy (2021) Vol. 21, Iss. 11, pp. 1253-1264
Closed Access
